Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer

Nahit Şendur M. A., AKSOY S., Bülent Akinci M., Ozdemir N., ŞENER DEDE D., Altundag K., ...More

Future Oncology, vol.11, no.6, pp.905-907, 2015 (SCI-Expanded, Scopus)

• Publication Type: Article / Article
• Volume: 11 Issue: 6
• Publication Date: 2015
• Doi Number: 10.2217/fon.15.6
• Journal Name: Future Oncology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.905-907
• Keywords: aromatase inhibitors, exemestane, ovarian suppression, premenopausal breast cancer, tamoxifen, BODY-MASS INDEX, ADJUVANT ENDOCRINE THERAPY, PLASMA ESTROGEN-LEVELS, TRIAL, WOMEN, RISK, ANASTROZOLE, LETROZOLE, TAMOXIFEN, AROMATASE
• Lokman Hekim University Affiliated: No